rs144292455
Positions:
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_001059.3(TACR3):c.824G>A(p.Trp275Ter) variant causes a stop gained change. The variant allele was found at a frequency of 0.000463 in 1,612,902 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: 𝑓 0.00038 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00047 ( 0 hom. )
Consequence
TACR3
NM_001059.3 stop_gained
NM_001059.3 stop_gained
Scores
5
1
1
Clinical Significance
Conservation
PhyloP100: 6.97
Genes affected
TACR3 (HGNC:11528): (tachykinin receptor 3) This gene belongs to a family of genes that function as receptors for tachykinins. Receptor affinities are specified by variations in the 5'-end of the sequence. The receptors belonging to this family are characterized by interactions with G proteins and 7 hydrophobic transmembrane regions. This gene encodes the receptor for the tachykinin neurokinin 3, also referred to as neurokinin B. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 18 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 4-103656258-C-T is Pathogenic according to our data. Variant chr4-103656258-C-T is described in ClinVar as [Pathogenic]. Clinvar id is 66084.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr4-103656258-C-T is described in Lovd as [Pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TACR3 | NM_001059.3 | c.824G>A | p.Trp275Ter | stop_gained | 3/5 | ENST00000304883.3 | NP_001050.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TACR3 | ENST00000304883.3 | c.824G>A | p.Trp275Ter | stop_gained | 3/5 | 1 | NM_001059.3 | ENSP00000303325 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000375 AC: 57AN: 151984Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
57
AN:
151984
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000307 AC: 77AN: 250942Hom.: 0 AF XY: 0.000295 AC XY: 40AN XY: 135610
GnomAD3 exomes
AF:
AC:
77
AN:
250942
Hom.:
AF XY:
AC XY:
40
AN XY:
135610
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000472 AC: 690AN: 1460918Hom.: 0 Cov.: 31 AF XY: 0.000466 AC XY: 339AN XY: 726780
GnomAD4 exome
AF:
AC:
690
AN:
1460918
Hom.:
Cov.:
31
AF XY:
AC XY:
339
AN XY:
726780
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000375 AC: 57AN: 151984Hom.: 0 Cov.: 32 AF XY: 0.000283 AC XY: 21AN XY: 74214
GnomAD4 genome
AF:
AC:
57
AN:
151984
Hom.:
Cov.:
32
AF XY:
AC XY:
21
AN XY:
74214
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
2
ALSPAC
AF:
AC:
2
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
8
ExAC
AF:
AC:
27
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Pathogenic:4
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Jun 06, 2022 | Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 29419413, 29886503, 31200363, 23643382, 21300340, 25525159, 26207952, 28436984, 30665703, 23329188, 30450471, 20332248, 26792935, 26239645, 22035731, 31980526, 34426522, 33363893, 31589614, 34055685, 22031817) - |
Pathogenic, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Mar 29, 2019 | DNA sequence analysis of the TACR3 gene demonstrated an apparently homozygous sequence change, c.824G>A, which results in the creation of a premature stop codon at amino acid position 275, p.Trp275*. This pathogenic sequence change is predicted to result in an abnormal transcript, which may be degraded, or may lead to the production of a truncated TACR3 protein with potentially abnormal function. This sequence change has been previously described in male patients with normosmic idiopathic hypogonadotropic hypogonadism in both homozygous and compound heterozygous state (Francou et al., 2011 and Gianetti et al., 2010). This sequence change has been described in the gnomAD database with a population frequency of 0.032% (rs144292455). - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | May 27, 2022 | This sequence change creates a premature translational stop signal (p.Trp275*) in the TACR3 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in TACR3 are known to be pathogenic (PMID: 20194706, 20332248, 22031817). This variant is present in population databases (rs144292455, gnomAD 0.06%). This premature translational stop signal has been observed in individual(s) with idiopathic hypogonadotropic hypogonadism (PMID: 33363893). ClinVar contains an entry for this variant (Variation ID: 66084). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. For these reasons, this variant has been classified as Pathogenic. - |
Pathogenic, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Jan 25, 2018 | - - |
Hypogonadotropic hypogonadism 11 with or without anosmia Pathogenic:3
Pathogenic, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Oct 04, 2021 | - - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Jun 01, 2010 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 27, 2017 | The TACR3 c.824G>A (p.Trp275Ter) variant is a stop-gained variant reported in four studies in which it is found in a total of 13 individuals with isolated gonadotropin-releasing hormone (GnRH) deficiency, including in three homozygotes, in three compound heterozygotes, in five heterozygotes, and in two individuals showing digenic inheritance (Gianetti et al. 2010; Quaynor et al. 2011; Xu et al. 2011; Francou et al. 2011). The variant was absent from over 800 controls, but is reported at a frequency of 0.00093 in the European American population of the Exome Sequencing Project. Based on the potential impact of stop-gained variants and the evidence from the literature, the p.Trp275Ter variant is classified as pathogenic for isolated GnRH deficiency. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population. - |
TACR3-related disorder Pathogenic:1
Pathogenic, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jun 22, 2024 | The TACR3 c.824G>A variant is predicted to result in premature protein termination (p.Trp275*). This variant has been reported in the compound heterozygous and homozygous states, as well as in combination with variants in other genes, to be causative for hypogonadotropic hypogonadism (see for example - Gianetti et al. 2010. PubMed ID: 20332248; Xu et al. 2011. PubMed ID: 21300340). This variant is reported in 0.065% of alleles in individuals of European (Non-Finnish) descent in gnomAD. Nonsense variants in TACR3 are expected to be pathogenic. This variant is interpreted as pathogenic. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Pathogenic
D
MutationTaster
Benign
A
Vest4
GERP RS
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
DS_AG_spliceai
Position offset: -2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at